Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person HSP90 is inactivated by binding to benzaquinoid ansamycins

Class:IdReaction:1218824
_displayNameHSP90 is inactivated by binding to benzaquinoid ansamycins
_doReleaseTRUE
_timestamp2011-11-23 11:11:55
authored[InstanceEdit:1972359] Orlic-Milacic, M, 2011-11-04
compartment[Compartment:70101] cytosol
created[InstanceEdit:1218828] Orlic-Milacic, Marija, 2011-02-17
disease[Disease:1500689] cancer
edited[InstanceEdit:1972360] D'Eustachio, P, 2011-11-07
[InstanceEdit:1972361] Matthews, L, 2011-11-07
[InstanceEdit:1990858] Jassal, B, 2011-11-07
[InstanceEdit:1990853] Wu, G, 2011-11-07
input[DefinedSet:1217511] Benzoquinoid ansamycins [cytosol]
[Complex:1221657] HSP90 [cytosol] [Homo sapiens]
[DefinedSet:1217511] Benzoquinoid ansamycins [cytosol]
isChimericFALSE
literatureReference[LiteratureReference:1218826] Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent
modified[InstanceEdit:1220607] Orlic-Milacic, Marija, 2011-02-22
[InstanceEdit:1221662] Orlic-Milacic, Marija, 2011-02-25
[InstanceEdit:1236376] Orlic-Milacic, Marija, 2011-03-24
[InstanceEdit:1247554] Orlic-Milacic, Marija, 2011-04-01
[InstanceEdit:1247610] Orlic-Milacic, Marija, 2011-04-04
[InstanceEdit:1643697] Orlic-Milacic, Marija, 2011-10-11
[InstanceEdit:1660495] Orlic-Milacic, Marija, 2011-10-13
[InstanceEdit:1667623] Orlic-Milacic, Marija, 2011-10-14
[InstanceEdit:1979631] Orlic-Milacic, Marija, 2011-11-08
[InstanceEdit:1990842] Orlic-Milacic, Marija, 2011-11-14
[InstanceEdit:1990860] Orlic-Milacic, Marija, 2011-11-14
[InstanceEdit:2023591] Matthews, L, 2011-12-09
[InstanceEdit:9830342] Matthews, Lisa, 2023-03-08
nameHSP90 is inactivated by binding to benzaquinoid ansamycins
output[Complex:1218829] HSP90:Benzoquinoid ansamycins [cytosol] [Homo sapiens]
releaseDate2011-12-06
reviewed[InstanceEdit:1990843] Greulich, H, 2011-11-15
[InstanceEdit:1990844] Savas, S, 2011-11-15
reviewStatus[ReviewStatus:9821382] five stars
species[Species:48887] Homo sapiens
stableIdentifier[StableIdentifier:2016431] R-HSA-1218824.2
summation[Summation:1218831] Benzoquinoid ansamycins (geldanamycin, herbimycin, and gelda...
(hasEvent)[Pathway:1169434] Signaling by constitutively active EGFR kinase domain mutants [Homo sapiens]
[Pathway:1236382] Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants [Homo sapiens]
[Pathway:5637810] Constitutive Signaling by EGFRvIII [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by HSP90 is inactivated by binding to benzaquinoid ansamycins (1218824)